Skip to content

Early Screening for Gestational Diabetes Mellitus

Early Screening for Gestational Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01026675
Acronym
DG2
Enrollment
1442
Registered
2009-12-04
Start date
2009-04-30
Completion date
2013-05-31
Last updated
2018-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Brief summary

The working hypothesis of this proposal is that screening for gestational diabetes mellitus as early as the 1st trimester is efficient for detecting the forthcoming presence or absence of gestational diabetes mellitus. The investigators long-term goal is the prevention of gestational diabetes mellitus onset i.e. the prevention of progression to gestational diabetes mellitus, in order to enable delivery of appropriate counselling, diagnostics and treatment for pregnant women, as well as to improve pregnancy outcomes. Therefore, robust 1st trimester screening criteria is needed. The overall objective of this proposal is to determine an accurate and valid 1st trimester 1h post 50g oral glucose challenge test plasma glucose cut-off value that is predictive of gestational diabetes mellitus onset.

Interventions

PROCEDURE50 g oral glucose challenge test - 75 g oral glucose tolerance test

50 g oral glucose challenge test at 6-13 weeks of gestation and 75 g oral glucose tolerance test at 24-28 weeks of gestation.

Sponsors

Canadian Diabetes Association
CollaboratorOTHER
Université de Sherbrooke
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age \> 18 yrs * Gestational age between 6 and 13 weeks from last menstrual period, * Alcohol \< 2 drinks/day * Not involved in regular high intensity physical activity * Singleton pregnancy * Otherwise good health status.

Exclusion criteria

* Type 1 or type 2 diabetes * Taking drugs interfering with glucose metabolism

Design outcomes

Primary

MeasureTime frameDescription
oral glucose challenge test plasma glucose value6-13 weeksthe sensitivity, specificity, positive and negative predictive values of oral glucose challenge test plasma glucose \>= 7.8 mmol/L during the 1st trimester (6-13 weeks of gestation), as compared with fasting 75g glucose oral glucose tolerance test performed between the 24th and 28th weeks of gestation (the Canadian Diabetes Association - CDA gold standard).

Secondary

MeasureTime frameDescription
oral glucose challenge test plasma glucose cut-off value6-13 weeks1st trimester 1h post 50g oral glucose challenge test plasma glucose cut-off value that offers optimal sensibility and specificity compared to the 75g oral glucose tolerance test performed between the 24th and 28th weeks of gestation, based on the ROC curve and the maximal likelihood ratio for a positive test.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026